Non-IgG antibodies have gained increasing importance in diagnostic and therapeutic applications with their inherent advantages compared with IgG antibodies. As one of the well-recognized experts in antibody engineering, Creative Biolabs is professional in applying advanced platforms for non-IgG therapeutic antibody research. Aided by our first-in-class technologies and professional scientists, we are dedicated to developing and utilizing non-IgG therapeutic antibodies, mainly IgM and IgA, as promising treatments for human influenza viral infection.